New Developments In Dystonia

Date/Time: Monday, October 22, 2018 - 11:45 AM to 1:00 PM
Type: Interactive Lunch Workshop
Room: Regency V

Session Overview

Chair: William T. Dauer, MD – University of Michigan Medical School
Co-Chair: Stewart Factor, DO – Emory University

The family of disorders known as the dystonias has seen enormous advances in recent years. These advances include a new definition and classification of all dystonias, new information on the pathogenesis of dystonia, new trends for the use of existing therapies, and an experimental pipeline for development of novel therapeutics. The goal of this session is to review the traditional viewpoints and emerging developments.

Objectives

  • To summarize novel information regarding the genetics and neuroanatomical and neurophysiological bases for various types of dystonia.

  • To describe traditional and emerging trends in botulinum toxin therapy, including new concepts regarding dose and dosing intervals, new toxin preparations, and current understanding of treatment failures.

  • To present the case for the need for novel therapeutics agents, and the different strategies being employed to develop novel therapeutics.